We are live on ! Find out more
ISPC icon

iSpecimen

6 hedge funds and large institutions have $183K invested in iSpecimen in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more capital invested

Capital invested by funds: $103K → $183K (+$79.7K)

3.34% more ownership

Funds ownership: 2.56%5.9% (+3.3%)

45% less funds holding

Funds holding: 116 (-5)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
6
Holders Change
-5
Holders Change %
-45.45%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
Closed
9
Calls
Puts
Net Calls
Net Calls Change

ISPC Hedge Fund Activity: Q3 2024 in Review

6 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q3 2024, worth a combined $183K — up 77% from $103K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ISPC and 4 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Jane Street, adding an estimated $113K. The largest seller was HRT Financial, exiting entirely with an estimated $14K sold.

  • 6 institutional investors held iSpecimen (ISPC) as of Q3 2024, down from 11 in Q2 2024.
  • Funds reported $183K of iSpecimen stock for Q3 2024, up 77% quarter-over-quarter.
  • 4 funds opened new iSpecimen positions in Q3 2024 and 9 closed out, a net change of -5 holders.
  • The largest iSpecimen buyer in Q3 2024 was Jane Street, an estimated $113K added.
  • The largest iSpecimen seller in Q3 2024 was HRT Financial, an estimated $14K sold.

Based on aggregated 13F filings for Q3 2024.